{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:48:36Z","timestamp":1792068516341,"version":"4.4.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1005086","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000}}],"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["TK214"],"award-info":[{"award-number":["TK214"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PSG776"],"award-info":[{"award-number":["PSG776"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PRG1911"],"award-info":[{"award-number":["PRG1911"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PRG2625"],"award-info":[{"award-number":["PRG2625"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["318918\/Z\/24\/Z"],"award-info":[{"award-number":["318918\/Z\/24\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P50HD104224-01"],"award-info":[{"award-number":["1P50HD104224-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hormonal contraceptives (HCs) are widely used and have well-documented population-level statistics. Previous studies with short follow-ups have focussed on individual HC use and side effects. However, the same aspects over longer periods, HC formulation switching, and the impact of genetic factors on HC side effects remain understudied due to the limited availability of suitable datasets. We investigated whether the Estonian Biobank (EstBB) is suitable for studying genetic risk for HC side effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      This is a longitudinal descriptive study combining prescribed HC purchase data collected from 2004 to 2022 with genetic and health data from 73,071 female EstBB HC users aged 15\u201355 at the time of purchase. HC usage was defined by the Anatomical Therapeutic Chemical (ATC) codes G02B, G03A, and G03HB01. Methods included calculating age-stratified annual user prevalence, inferring usage periods from purchases, assessing formulation switching, identifying the International Classification of Diseases, Tenth Revision (ICD-10)-based side effect-related diagnoses and thromboembolism risk factors, and assessing carrier status for Factor V Leiden (FVL, rs6025) and prothrombin G20210A (PTM, rs1799963) genetic variants as proof-of-concept. Over 19 years, 20 HC formulations with five administration routes (oral pills, transdermal patches, vaginal rings, subdermal implants, intrauterine devices) were used. In the EstBB, combined HCs were the most commonly used among users aged 15\u201329, while progestin-only HC use increased with age and over time, comparable to the Estonian population. Overall, 64.2% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200946,920) of users switched formulations at least once, with 17.7% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912,929) being rapid switchers. Side effect-related diagnoses were observed in 23.1% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092,982) of rapid switchers, with excessive\/irregular menstrual bleeding being the most common. Genetic analysis revealed that 5.3% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093,886) of users carried at least one variant previously associated with increased thrombosis risk (3.5% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092,556) carried FVL only, 1.8% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091,276) PTM only, and 0.07% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200954) both). Carriers of thrombosis-associated variants had a significantly higher percentage of thrombosis (6.5%) than non-carriers (4.2%; OR = 1.61, 95% CI [1.40, 1.84],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The study is limited by the use of administrative medication purchase records, which may not reflect actual HC use. Additionally, diagnoses identified near the HC usage period may not represent true side effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides insights into real-world HC usage with longitudinal, individual-level detail that is not available in population-level statistics. We show that EstBB has a robust dataset for studying the impact of genetic factors on HC side effects and disease risk. The identified HC user profiles offer a framework for genetic analyses of HC rapid switching and discontinuation. Our approach can be replicated in other biobanks to validate findings across populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1005086","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:48:40Z","timestamp":1779299320000},"page":"e1005086","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prescribed hormonal contraceptive use trends in the Estonian Biobank: A longitudinal observational study"],"prefix":"10.1371","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2885-6241","authenticated-orcid":true,"given":"Jelisaveta","family":"D\u017eigurski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5845-3534","authenticated-orcid":true,"given":"M\u00e4rt","family":"M\u00f6ls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"L\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2764-6787","authenticated-orcid":true,"given":"Hannah","family":"Currant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9651-4107","authenticated-orcid":true,"given":"Mall","family":"Eltermaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Estonian Biobank Research Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reedik","family":"M\u00e4gi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5323-3102","authenticated-orcid":true,"given":"Lili","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1501-9030","authenticated-orcid":true,"given":"Triin","family":"Laisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"pmed.1005086.ref001","unstructured":"United Nations Department of Economic and Social Affairs, Population Division. World Family Planning 2022: meeting the changing needs for family planning: contraceptive use by age and method. New York: United Nations; 2022 [cited 30 Oct 2025]. Available from: https:\/\/www.un.org\/development\/desa\/pd\/sites\/files\/files\/documents\/2023\/Feb\/undesa_pd_2022_world-family-planning.pdf"},{"issue":"3","key":"pmed.1005086.ref002","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, challenges, and guiding treatment","volume":"106","author":"KM Hoeger","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"pmed.1005086.ref003","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/13625187.2018.1550576","article-title":"Hormonal contraception in women with endometriosis: a systematic review","volume":"24","author":"G Grandi","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"pmed.1005086.ref004","article-title":"Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis","volume":"5","author":"M Bofill Rodriguez","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"pmed.1005086.ref005","doi-asserted-by":"crossref","first-page":"2247093","DOI":"10.1080\/09513590.2023.2247093","article-title":"Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice","volume":"39","author":"AR Genazzani","year":"2023","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"pmed.1005086.ref006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.contraception.2014.09.008","article-title":"Stopping and switching contraceptive methods: findings from Contessa, a prospective longitudinal study of women of reproductive age in England","volume":"91","author":"K Wellings","year":"2015","journal-title":"Contraception"},{"issue":"1","key":"pmed.1005086.ref007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/13625187.2024.2415361","article-title":"Discontinuation of long-acting reversible contraception: a retrospective Dutch study in general practice","volume":"30","author":"TAM Teunissen","year":"2025","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"pmed.1005086.ref008","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"\u00d8 Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"pmed.1005086.ref009","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082801","article-title":"Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study","volume":"388","author":"H Yonis","year":"2025","journal-title":"BMJ"},{"key":"pmed.1005086.ref010","unstructured":"European Medicines Agency. Combined hormonal contraceptives \u2013 referral. 2014 [cited 12 Mar 2025]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/combined-hormonal-contraceptives"},{"key":"pmed.1005086.ref011","volume-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2025","edition":"6"},{"key":"pmed.1005086.ref012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"AT Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"pmed.1005086.ref013","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/13625187.2021.1931839","article-title":"Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study","volume":"26","author":"K Kurvits","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"2","key":"pmed.1005086.ref014","first-page":"120","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"E Previtali","year":"2011","journal-title":"Blood Transfus"},{"issue":"6","key":"pmed.1005086.ref015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1472-8206.2007.00515.x","article-title":"Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study","volume":"21","author":"K Lacut","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"issue":"5","key":"pmed.1005086.ref016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005316","article-title":"Antidepressants, depression, and venous thromboembolism risk: large prospective study of UK women","volume":"6","author":"L Parkin","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"pmed.1005086.ref017","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.contraception.2016.07.011","article-title":"Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review","volume":"94","author":"EN Berry-Bibee","year":"2016","journal-title":"Contraception"},{"key":"pmed.1005086.ref018","doi-asserted-by":"crossref","DOI":"10.1016\/S0049-3848(19)30362-7","article-title":"Antidepressants: bleeding or thrombosis?","volume":"181","author":"S Hoirisch-Clapauch","year":"2019","journal-title":"Thromb Res"},{"issue":"6","key":"pmed.1005086.ref019","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1538-7836.2010.03840.x","article-title":"A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin","volume":"8","author":"BK Mahmoodi","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"pmed.1005086.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Factor V Leiden thrombophilia","volume":"13","author":"JL Kujovich","year":"2011","journal-title":"Genet Med"},{"issue":"6","key":"pmed.1005086.ref021","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0002-8703(03)00519-2","article-title":"Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies","volume":"146","author":"RJ Kim","year":"2003","journal-title":"Am Heart J"},{"issue":"19","key":"pmed.1005086.ref022","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012877","article-title":"Inherited thrombophilia and the risk of arterial ischemic stroke: a systematic review and meta-analysis","volume":"8","author":"T Chiasakul","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"pmed.1005086.ref023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2023.09.012","article-title":"The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank","volume":"230","author":"V Lo Faro","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"pmed.1005086.ref024","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1038\/s41467-025-58465-3","article-title":"The Estonian Biobank\u2019s journey from biobanking to personalized medicine","volume":"16","author":"L Milani","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"pmed.1005086.ref025","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1038\/s41467-020-19742-5","article-title":"The genetic architecture of sporadic and multiple consecutive miscarriage","volume":"11","author":"T Laisk","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"pmed.1005086.ref026","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ejendo\/lvae094","article-title":"Uncovering the shared genetic components of thyroid disorders and reproductive health","volume":"191","author":"J Figuer\u00eado","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"pmed.1005086.ref027","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/s41591-025-03543-8","article-title":"Atlas of genetic and phenotypic associations across 42 female reproductive health diagnoses","volume":"31","author":"N Pujol Gualdo","year":"2025","journal-title":"Nat Med"},{"key":"pmed.1005086.ref028","doi-asserted-by":"crossref","first-page":"100914","DOI":"10.1016\/j.lanepe.2024.100914","article-title":"Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian Biobank","volume":"41","author":"M Alver","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"pmed.1005086.ref029","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41431-018-0300-6","article-title":"Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records","volume":"27","author":"T Tasa","year":"2019","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"pmed.1005086.ref030","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","article-title":"Participation bias in the UK Biobank distorts genetic associations and downstream analyses","volume":"7","author":"T Schoeler","year":"2023","journal-title":"Nat Hum Behav"},{"issue":"3","key":"pmed.1005086.ref031","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyae054","article-title":"Reweighting UK Biobank corrects for pervasive selection bias due to volunteering","volume":"53","author":"S van Alten","year":"2024","journal-title":"Int J Epidemiol"},{"issue":"10","key":"pmed.1005086.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"JP Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"issue":"10","key":"pmed.1005086.ref033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"EI Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"pmed.1005086.ref034","first-page":"1","article-title":"Combined estrogen\u2013progestogen contraceptives and combined estrogen\u2013progestogen menopausal therapy","volume":"91","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2007","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"pmed.1005086.ref035","unstructured":"Statistics Estonia. RV021: population, 1 January by sex, year and age group. Tallinn: Statistics Estonia Statistical Database; 2026 [cited 02 Feb 2026]. Available from: https:\/\/andmed.stat.ee\/en\/stat\/rahvastik__rahvastikunaitajad-ja-koosseis__rahvaarv-ja-rahvastiku-koosseis\/RV021\/table\/tableViewLayout2"},{"key":"pmed.1005086.ref036","unstructured":"Estonian Health Insurance Fund (Tervisekassa). Annual reports. [cited 28 Feb 2026]. Available from: https:\/\/tervisekassa.ee\/en\/organisation\/annual-reports"},{"issue":"2","key":"pmed.1005086.ref037","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/jpm5020096","article-title":"Linking a population biobank with national health registries-the estonian experience","volume":"5","author":"L Leitsalu","year":"2015","journal-title":"J Pers Med"},{"issue":"2","key":"pmed.1005086.ref038","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/jwh.2010.2001","article-title":"Characteristics of the menstrual cycle after discontinuation of oral contraceptives","volume":"20","author":"CL Nassaralla","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"issue":"6","key":"pmed.1005086.ref039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007848","article-title":"Mechanistic model of hormonal contraception","volume":"16","author":"AA Wright","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"pmed.1005086.ref040","doi-asserted-by":"crossref","first-page":"769187","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"L Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"pmed.1005086.ref041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093792","article-title":"Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France","volume":"9","author":"A Tricotel","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"pmed.1005086.ref042","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/aogs.14384","article-title":"Systemic hormonal contraception and risk of venous thromboembolism","volume":"101","author":"O Heikinheimo","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"pmed.1005086.ref043","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003401","article-title":"Continuation rates of oral hormonal contraceptives in a cohort of first-time users: a population-based registry study, Sweden 2005\u20132010","volume":"3","author":"A Josefsson","year":"2013","journal-title":"BMJ Open"},{"key":"pmed.1005086.ref044","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajog.2018.12.022","article-title":"Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants","volume":"220","author":"RG Simmons","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1005086.ref045","article-title":"Arterial and venous thrombosis.","volume-title":"Harrison\u2019s principles of internal medicine","author":"JE Freedman","year":"2025","edition":"22"},{"issue":"22","key":"pmed.1005086.ref046","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","article-title":"Robust relationship inference in genome-wide association studies","volume":"26","author":"A Manichaikul","year":"2010","journal-title":"Bioinformatics"},{"issue":"7","key":"pmed.1005086.ref047","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ejhg.2017.51","article-title":"Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel","volume":"25","author":"M Mitt","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"pmed.1005086.ref048","unstructured":"Barrett T, Dowle M, Srinivasan A, Gorecki J, Chirico M, Hocking T. data.table: Extension of data.frame. R package version 1.15.4. 2024 [cited 28 Feb 2026]. Available from: https:\/\/CRAN.R-project.org\/package=data.table"},{"key":"pmed.1005086.ref049","unstructured":"Wickham H, Fran\u00e7ois R, Henry L, M\u00fcller K, Vaughan D. dplyr: A Grammar of Data Manipulation. R package version 1.1.4. 2023 [cited 28 Feb 2026]. Available from: https:\/\/CRAN.R-project.org\/package=dplyr"},{"key":"pmed.1005086.ref050","unstructured":"Wickham H, Girlich M. tidyr: Tidy Messy Data. R package version 1.2.0. 2022 [cited 28 Feb 2026]. Available from: https:\/\/tidyr.tidyverse.org"},{"key":"pmed.1005086.ref051","unstructured":"Wickham H. stringr: Simple, Consistent Wrappers for Common String Operations. R package version 1.5.1. 2023 [cited 28 Feb 2026]. Available from: https:\/\/CRAN.R-project.org\/package=stringr"},{"issue":"3","key":"pmed.1005086.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i03","article-title":"Dates and times made easy with lubridate","volume":"40","author":"G Grolemund","year":"2011","journal-title":"J Stat Softw"},{"key":"pmed.1005086.ref053","unstructured":"Ren K, Russell K. formattable: Create \u2018Formattable\u2019 Data Structures. R package version 0.2.1. 2021 [cited 28 Feb 2026]. Available from: https:\/\/CRAN.R-project.org\/package=formattable"},{"key":"pmed.1005086.ref054","unstructured":"Aragon T. epitools: Epidemiology Tools. R package version 0.5-10.1. 2020 [cited 28 Feb 2026]. Available from: https:\/\/cran.r-project.org\/web\/packages\/epitools\/epitools.pdf"},{"key":"pmed.1005086.ref055","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016"},{"key":"pmed.1005086.ref056","unstructured":"Brunson JC, Read QD. ggalluvial: Alluvial Plots in \u2018ggplot2\u2019. R package version 0.12.5. 2023 [cited 28 Feb 2026]. Available from: http:\/\/corybrunson.github.io\/ggalluvial\/"},{"key":"pmed.1005086.ref057","author":"S Garnier","year":"2024","journal-title":"viridis(Lite) \u2013 colorblind-friendly color maps for R"},{"key":"pmed.1005086.ref058","unstructured":"Wickham H, Pedersen T, Seidel D. scales: Scale Functions for Visualization. R package version 1.3.0. 2023 [cited 28 Feb 2026]. Available from: https:\/\/CRAN.R-project.org\/package=scales"},{"key":"pmed.1005086.ref059","unstructured":"Pedersen T. patchwork: The Composer of Plots. R package version 1.2.0. 2024 [cited 28 Feb 2026]. Available from: https:\/\/CRAN.R-project.org\/package=patchwork"},{"key":"pmed.1005086.ref060","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2022 [cited 10 June 2025]. Available from: https:\/\/www.R-project.org\/"},{"key":"pmed.1005086.ref061","unstructured":"Tervisestatistika ja Terviseuuringute. TKU40: Body mass index categories by sex and age group. 2025 [cited 27 Jun 2025]. Available from: https:\/\/statistika.tai.ee\/pxweb\/en\/Andmebaas\/Andmebaas__05Uuringud__02TKU__04Liikumine\/TKU40.px\/"},{"issue":"2","key":"pmed.1005086.ref062","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/bmjsrh-2023-201856","article-title":"Contraception prescribing in England during the COVID-19 pandemic","volume":"50","author":"T Begum","year":"2024","journal-title":"BMJ Sex Reprod Health"},{"issue":"4","key":"pmed.1005086.ref063","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2010.03.011","article-title":"Patterns of contraceptive use before and after an abortion: results from a nationally representative survey of women undergoing an abortion in France","volume":"82","author":"C Moreau","year":"2010","journal-title":"Contraception"},{"issue":"8","key":"pmed.1005086.ref064","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jtha.2024.03.014","article-title":"Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women","volume":"22","author":"JPL Verlaan","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"1","key":"pmed.1005086.ref065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/aogs.13055","article-title":"Contraceptive use in the Nordic countries","volume":"96","author":"I Lindh","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"pmed.1005086.ref066","article-title":"Hormonal contraceptive use in Denmark 2010-2019","volume":"68","author":"SI Kristensen","year":"2021","journal-title":"Dan Med J"},{"issue":"3","key":"pmed.1005086.ref067","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/bmjsrh-2021-201260","article-title":"Time trends in contraceptive prescribing in UK primary care 2000-2018: a repeated cross-sectional study","volume":"48","author":"TJ Pasvol","year":"2022","journal-title":"BMJ Sex Reprod Health"},{"key":"pmed.1005086.ref068","unstructured":"State Agency of Medicines (Ravimiamet). About the state agency of medicines. Tartu: State Agency of Medicines; 2025 [cited: 28 Feb 2026]. Available from: https:\/\/www.ravimiamet.ee\/en"},{"issue":"6","key":"pmed.1005086.ref069","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1055\/s-0038-1665437","article-title":"Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?","volume":"78","author":"CM Schambeck","year":"1997","journal-title":"Thromb Haemost"},{"issue":"3","key":"pmed.1005086.ref070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AOG.0b013e3181d018a8","article-title":"Family history of venous thromboembolism and identifying factor V Leiden carriers during pregnancy","volume":"115","author":"AL Horton","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"4","key":"pmed.1005086.ref071","doi-asserted-by":"crossref","first-page":"100502","DOI":"10.1016\/j.bpsgos.2025.100502","article-title":"Antidepressant switching as a proxy phenotype for drug nonresponse: investigating clinical, demographic, and genetic characteristics","volume":"5","author":"CWH Lo","year":"2025","journal-title":"Biol Psychiatry Glob Open Sci"},{"issue":"12","key":"pmed.1005086.ref072","first-page":"1499","article-title":"Managing adverse effects of hormonal contraceptives","volume":"82","author":"N Grossman Barr","year":"2010","journal-title":"Am Fam Physician"},{"key":"pmed.1005086.ref073","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.rr7303a1","article-title":"U.S. selected practice recommendations for contraceptive use, 2024","volume":"73","author":"KM Curtis","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"pmed.1005086.ref074","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2015.03.016","article-title":"Pharmacy claims data versus patient self-report to measure contraceptive method continuation","volume":"92","author":"JE Triebwasser","year":"2015","journal-title":"Contraception"},{"issue":"3","key":"pmed.1005086.ref075","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41562-024-02061-w","article-title":"The impact of self-report inaccuracy in the UK Biobank and its interplay with selective participation","volume":"9","author":"T Schoeler","year":"2025","journal-title":"Nat Hum Behav"},{"key":"pmed.1005086.ref076","unstructured":"Estonian Health Insurance Fund (Tervisekassa). Soodusravimid [Subsidised medicines]. Tallinn: Estonian Health Insurance Fund; 2026 [cited 02 Feb 2026]. Available from: https:\/\/tervisekassa.ee\/partnerile\/ravimitest\/soodusravimid"},{"key":"pmed.1005086.ref077","doi-asserted-by":"crossref","first-page":"101042","DOI":"10.1016\/j.yfrne.2022.101042","article-title":"Moving beyond the mean: promising research pathways to support a precision medicine approach to hormonal contraception","volume":"68","author":"SE Hill","year":"2023","journal-title":"Front Neuroendocrinol"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1005086","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:51:01Z","timestamp":1780077061000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005086"}},"subtitle":[],"editor":[{"given":"Isabelle","family":"Dehaene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":77,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1005086","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}